Search

everythinglearnresearchcommunity

for

Search:↓

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Dianabol boosts muscle growth but has serious health risks and legal issues.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.